580 related articles for article (PubMed ID: 18218096)
1. The androgen receptor can signal through Wnt/beta-Catenin in prostate cancer cells as an adaptation mechanism to castration levels of androgens.
Schweizer L; Rizzo CA; Spires TE; Platero JS; Wu Q; Lin TA; Gottardis MM; Attar RM
BMC Cell Biol; 2008 Jan; 9():4. PubMed ID: 18218096
[TBL] [Abstract][Full Text] [Related]
2. Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer.
Terry S; Yang X; Chen MW; Vacherot F; Buttyan R
J Cell Biochem; 2006 Oct; 99(2):402-10. PubMed ID: 16741972
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer.
Wang G; Wang J; Sadar MD
Cancer Res; 2008 Dec; 68(23):9918-27. PubMed ID: 19047173
[TBL] [Abstract][Full Text] [Related]
4. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
[TBL] [Abstract][Full Text] [Related]
5. Increased Akt signaling resulting from the loss of androgen responsiveness in prostate cancer.
Dulinska-Litewka J; McCubrey JA; Laidler P
Curr Med Chem; 2013; 20(1):144-57. PubMed ID: 23033951
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.
Li X; Martinez-Ferrer M; Botta V; Uwamariya C; Banerjee J; Bhowmick NA
Oncogene; 2011 Jan; 30(2):167-77. PubMed ID: 20818421
[TBL] [Abstract][Full Text] [Related]
7. Wnt3a growth factor induces androgen receptor-mediated transcription and enhances cell growth in human prostate cancer cells.
Verras M; Brown J; Li X; Nusse R; Sun Z
Cancer Res; 2004 Dec; 64(24):8860-6. PubMed ID: 15604245
[TBL] [Abstract][Full Text] [Related]
8. A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.
Amir AL; Barua M; McKnight NC; Cheng S; Yuan X; Balk SP
J Biol Chem; 2003 Aug; 278(33):30828-34. PubMed ID: 12799378
[TBL] [Abstract][Full Text] [Related]
9. Linking beta-catenin to androgen-signaling pathway.
Yang F; Li X; Sharma M; Sasaki CY; Longo DL; Lim B; Sun Z
J Biol Chem; 2002 Mar; 277(13):11336-44. PubMed ID: 11792709
[TBL] [Abstract][Full Text] [Related]
10. Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer.
Patel R; Brzezinska EA; Repiscak P; Ahmad I; Mui E; Gao M; Blomme A; Harle V; Tan EH; Malviya G; Mrowinska A; Loveridge CJ; Rushworth LK; Edwards J; Ntala C; Nixon C; Hedley A; Mackay G; Tardito S; Sansom OJ; Leung HY
Cancer Res; 2020 Feb; 80(3):576-590. PubMed ID: 31719098
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
12. In vitro evidence for complex modes of nuclear beta-catenin signaling during prostate growth and tumorigenesis.
Chesire DR; Ewing CM; Gage WR; Isaacs WB
Oncogene; 2002 Apr; 21(17):2679-94. PubMed ID: 11965541
[TBL] [Abstract][Full Text] [Related]
13. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
[TBL] [Abstract][Full Text] [Related]
14. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors.
Singh R; Artaza JN; Taylor WE; Braga M; Yuan X; Gonzalez-Cadavid NF; Bhasin S
Endocrinology; 2006 Jan; 147(1):141-54. PubMed ID: 16210377
[TBL] [Abstract][Full Text] [Related]
15. Roles and regulation of Wnt signaling and beta-catenin in prostate cancer.
Verras M; Sun Z
Cancer Lett; 2006 Jun; 237(1):22-32. PubMed ID: 16023783
[TBL] [Abstract][Full Text] [Related]
16. Effects of WNT/beta-catenin pathway activation on signaling through T-cell factor and androgen receptor in prostate cancer cell lines.
Cronauer MV; Schulz WA; Ackermann R; Burchardt M
Int J Oncol; 2005 Apr; 26(4):1033-40. PubMed ID: 15753999
[TBL] [Abstract][Full Text] [Related]
17. Secreted Frizzled-related protein-1 is a negative regulator of androgen receptor activity in prostate cancer.
Kawano Y; Diez S; Uysal-Onganer P; Darrington RS; Waxman J; Kypta RM
Br J Cancer; 2009 Apr; 100(7):1165-74. PubMed ID: 19277043
[TBL] [Abstract][Full Text] [Related]
18. Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes.
Kim WK; Olson AW; Mi J; Wang J; Lee DH; Le V; Hiroto A; Aldahl J; Nenninger CH; Buckley AJ; Cardiff R; You S; Sun Z
Nat Commun; 2022 Jul; 13(1):4364. PubMed ID: 35902588
[TBL] [Abstract][Full Text] [Related]
19. Androgen signaling is a confounding factor for β-catenin-mediated prostate tumorigenesis.
Lee SH; Luong R; Johnson DT; Cunha GR; Rivina L; Gonzalgo ML; Sun Z
Oncogene; 2016 Feb; 35(6):702-14. PubMed ID: 25893287
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Wnt gene expression in prostate cancer: mutual inhibition by WNT11 and the androgen receptor.
Zhu H; Mazor M; Kawano Y; Walker MM; Leung HY; Armstrong K; Waxman J; Kypta RM
Cancer Res; 2004 Nov; 64(21):7918-26. PubMed ID: 15520198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
